Today: 10 June 2026
KLA stock price holds near $1,500 as Intel slump and earnings countdown drive volatility
23 January 2026
1 min read

KLA stock price holds near $1,500 as Intel slump and earnings countdown drive volatility

New York, January 23, 2026, 13:22 EST — Regular session

  • KLA shares were little changed near $1,500 after an early dip of more than 3%
  • Intel’s sharp slide kept pressure on chip-related names, including toolmakers
  • Focus shifts to KLA’s Jan. 29 results and what it says about customer spending

KLA Corp shares were little changed at $1,499.58 in early afternoon trading, after dipping as much as 3.2% earlier in the session. The stock ranged from $1,452.01 to $1,509.45.

The chipmaking equipment supplier reports fiscal second-quarter results on Jan. 29 after the U.S. market close, with an earnings call scheduled for 2 p.m. PT. Investors are looking for fresh signals on capital spending — the money chipmakers put into new plants and tools.

That backdrop tightened after Intel warned late Thursday that it struggled to meet demand for server chips used in AI data centers and forecast quarterly revenue and profit below estimates. Chief executive Lip-Bu Tan told analysts, “In the short term, I’m disappointed that we are not able to fully meet the demand,” while Intel shares were down about 17% on Friday. Reuters

Other chip toolmakers were mixed. Applied Materials rose about 0.6%, while Lam Research fell roughly 1.3% and ASML slid about 1.0%.

KLA slipped 1.3% to $1,500.00 in Thursday’s session and ended about 5% below its 52-week high of $1,581.34 hit on Jan. 16, MarketWatch data showed.

Analyst targets have been moving as the stock has climbed. Deutsche Bank raised its price target to $1,560 from $1,250 on Jan. 21, while maintaining a hold rating, Benzinga data showed.

KLA’s most recent quarterly outlook, issued with its October results, called for second-quarter revenue of about $3.225 billion plus or minus $150 million and non-GAAP earnings of about $8.70 per share plus or minus 78 cents.

KLA sells inspection and measurement tools that help chipmakers spot defects and keep their manufacturing steps on track. As chips get more complex, those checks tend to multiply, which can support demand even when parts of the chip cycle soften.

But the setup carries risk. If KLA’s outlook disappoints or customers start trimming factory spending after Intel’s warning, the group can reprice fast — and Friday’s whipsaw in KLA was a reminder.

Next up is Jan. 29, when KLA reports after the bell and updates its outlook, giving the market a read on how chipmakers are spending heading into 2026.

Stock Market Today

  • Trulieve First U.S. Cannabis Firm Listed on NYSE
    June 10, 2026, 9:54 AM EDT. Trulieve made history as the first U.S. cannabis company listed on the New York Stock Exchange (NYSE). This milestone follows recent regulatory adjustments easing cannabis stock listings. The move signals confidence in the medical marijuana sector's growth potential and sets a precedent for other cannabis firms eyeing major exchange listings.

Latest articles

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

10 June 2026
Rigetti Computing plunged 9.55% to $19.69 Tuesday and dipped further premarket after director Ray O. Johnson filed to sell 122,188 shares worth $2.6 million, testing investor confidence following a recent rally on news of a potential $100 million U.S. Commerce Department quantum-computing award, with traders watching for binding funding terms amid ongoing volatility.
PATH slips again, investors keep questioning AI automation bet

PATH slips again, investors keep questioning AI automation bet

10 June 2026
UiPath shares slid 3.76% to $10.75 and dropped another 1.49% pre-market as investors focused on slowing annual recurring revenue growth—up 12% to $1.901 billion versus 17% revenue growth—raising doubts about AI automation’s impact on recurring sales; second-quarter ARR guidance of $1.929–$1.934 billion is now the key number for PATH’s stock direction.
UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week
Previous Story

UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week

HBAN stock slips as Huntington tees up new debt sale ahead of Cadence deal — what to watch next week
Next Story

HBAN stock slips as Huntington tees up new debt sale ahead of Cadence deal — what to watch next week

Go toTop